Bioheart set to buy Polish ECG firm
This article was originally published in Clinica
Executive Summary
Heart failure and cardiovascular disease specialist Bioheart is on the verge of making its first company acquisition, with the purchase of MedicAlgorithmics, a Polish firm focused on developing electrocardiogram (ECG) technology. The deal, which is expected to close within the next 60-90 days, will see Bioheart gain worldwide rights to MedicAlgorithmics’ lead product, the Pocket ECG, a real-time wireless heart monitor and diagnostic system. The CE-marked product is described by Warsaw-based MedicAlgorithmics as being similar in size to an MP3 player, and is designed to automatically analyse a patent's heart beat and wirelessly transmit the data directly to a physician for the diagnosis, monitoring and potential treatment of arrhythmias and atrial fibrillation. Financial details were not disclosed.